Literature DB >> 16861927

Dormancy of solitary metastatic cells.

Jason L Townson1, Ann F Chambers.   

Abstract

After arriving in a secondary site metastatic cells may begin proliferating, undergo apoptosis or remain as solitary dormant cells. The process of metastasis, although dangerous, is extremely inefficient with the majority of the cells undergoing apoptosis and thus becoming clinically irrelevant. Of the cells that begin proliferating, the few that make it past the micrometastasis stage may be of immediate clinical relevance. Dormant cells, while not of immediate clinical concern, are believed to be at least in part responsible for cancer recurrence that can occur decades after apparently successful initial treatment. Dormant solitary cells are different from "dormant" micrometastases, in which active proliferation is balanced by apoptosis. The mechanisms of cell cycle regulation and the function of the molecules regulating this process are well understood. However, there is relatively little known about the mechanisms controlling cell cycle regulation and dormancy of solitary metastatic cells. There are several inherent difficulties impeding the study of solitary cells. This review paper will examine the models used in the study of dormant solitary metastatic cells, methods of imaging and studying these cells, the molecular mechanisms believed to be responsible for solitary cell dormancy, and finally the unique treatment challenges posed by these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861927     DOI: 10.4161/cc.5.16.2864

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  56 in total

1.  Visualizing extravasation dynamics of metastatic tumor cells.

Authors:  Konstantin Stoletov; Hisashi Kato; Erin Zardouzian; Jonathan Kelber; Jing Yang; Sanford Shattil; Richard Klemke
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

2.  Mechanisms of tumor cell extravasation in an in vitro microvascular network platform.

Authors:  Michelle B Chen; Jordan A Whisler; Jessie S Jeon; Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2013-10       Impact factor: 2.192

Review 3.  Dormancy of metastatic melanoma.

Authors:  Liliana Ossowski; Julio A Aguirre-Ghiso
Journal:  Pigment Cell Melanoma Res       Date:  2009-10-19       Impact factor: 4.693

4.  Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.

Authors:  Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

Review 5.  Rethinking the metastatic cascade as a therapeutic target.

Authors:  Lida A Mina; George W Sledge
Journal:  Nat Rev Clin Oncol       Date:  2011-04-19       Impact factor: 66.675

Review 6.  Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.

Authors:  Michelle M McDonald; Jesus Delgado-Calle
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

Review 7.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

8.  Modeling boundary conditions for balanced proliferation in metastatic latency.

Authors:  Donald P Taylor; Jakob Z Wells; Andrej Savol; Chakra Chennubhotla; Alan Wells
Journal:  Clin Cancer Res       Date:  2013-01-17       Impact factor: 12.531

9.  In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells.

Authors:  Dmitry A Nedosekin; Vladislav V Verkhusha; Alexander V Melerzanov; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Chem Biol       Date:  2014-05-08

Review 10.  Influence of diet on metastasis and tumor dormancy.

Authors:  Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.